| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000003620 |
| Receipt No. | R000004362 |
| Official scientific title of the study | Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study |
| Date of disclosure of the study information | 2010/05/17 |
| Last modified on | 2018/12/01 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study | |
| Title of the study (Brief title) | Effects of Aggressive Lipid Lowering Therapy With Atorvastatin on the Fibrous cap Thickness of Thin-cap Fibroatheroma: Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Study | |
| Region |
|
|
| Condition | ||
| Condition | Acute Coronary Syndrome | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This is an exploratory study aiming to elucidate the mechanism underlying plaque stabilization of statin treatment using Optical Coherence Tomography |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | For the plaques evaluated by OCT, what are the differences in plaque-stabilizing effects of atorvastatin in plaques with different characteristics (fibrous cap thickness)? |
| Key secondary outcomes | 1. Are LDL-C and fibrous-cap thickness inversely-correlated?
2. Are plaque volume and fibrous-cap thickness inversely-correlated? 3. Does atorvastatin suppress new plaque formation? |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 10 to 20 mg pitavastatin daily started within 24 hours of PCI to maintain LDL-cho level less than 70mg/dl | |
| Interventions/Control_2 | Control | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with acute coronary syndrome (including ST-segment elevation acute myocardial infarction, non-ST-segment elevation myocardial infarction and unstable angina).
2. Patients who have at least one critical stenosis involving 75% or more of the stenosis 3. LDL-cho level between 100mg/dl and 180mg/dl 4. Patients providing written consent for participation in this clinical trial on their own volition after receiving a thorough explanation about the study |
|||
| Key exclusion criteria | 1. Patients who will undergo elective percutaneous coronary intervention,
2. Patients who received thrombolytic therapy 3. Previous statin treatment 4. Severe left ventricular dysfunction (Ejection fraction <40% by echocardiogram), 5. Uncontrolled severe diabetes mellitus (HbA1c >12.0%). |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Tohru Masuyama |
| Organization | Hyogo College of Medicine |
| Division name | Cardiovascular Division |
| Address | 1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 6638501 JAPAN |
| TEL | 0798-45-6553 |
| Public contact | |
| Name of contact person | Kenichi Fujii |
| Organization | Hyogo College of Medicine |
| Division name | Cardiovascular Division |
| Address | 1-1 Mukogawa-cho, Nishinomiya-city, Hyogo 6638501 JAPAN |
| TEL | 0798-45-6553 |
| Homepage URL | |
| kfujii@hyo-med.ac.jp | |
| Sponsor | |
| Institute | Hyogo College of Medicine
Cardiovascular Division |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004362 |